ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000270462.1	Selumetinib	Breast invasive carcinoma	0.047235631	Resistant
ENSG00000270462.1	Selumetinib	Colon adenocarcinoma	0.020204831	Sensitive